Kim, Ji Geun
Yang, Hyunjung
Seo, Deachul
Lee, Gayeon
Park, Mijeong
McReynolds, Larkin S.
Amsel, Lawrence V.
Park, Soo Hyun
Hur, Juyoen
Kim, Young-Hoon
Han, Sanghoon
Funding for this research was provided by:
Yonsei Signature Research Cluster Program (2022-22-0006, 2022-22-0006, 2022-22-0006, 2022-22-0006, 2022-22-0006, 2022-22-0006, 2022-22-0006, 2022-22-0006, 2022-22-0006)
National Institute on Drug Abuse (3R01DA038154-05W1, 3R01DA038154-05W1)
Article History
Received: 19 July 2023
Accepted: 16 June 2025
First Online: 9 July 2025
Declarations
:
: This study was reviewed and approved by the Institutional Review Board (IRB) of Yonsei University in Korea (Approval Number: 7001988-202106-HR-1244-02) and the IRB of Columbia University in the US (Protocol Number 7994). All the participants were informed of their right to discontinue the survey at any time without any prejudice, and guaranteed anonymity and confidentiality. All the participants gave their written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.